Patent · US Active

Diagnostic devices and methods

US10890590B2 · kind B2 · utility

0Cited by
67References
37Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 30, 2015
Grant dateJan 12, 2021
Priority date—
Expiry dateMay 3, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/59
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Apparatus is disclosed for identifying at least a first target condition in a human or animal body. The apparatus comprises one or more test portions for identifying a first analyte in a biological sample from the body, the first analyte providing a marker of the first target condition, and a second analyte in the biological sample, the second analyte being different from the first analyte. The apparatus is configured to identify the first target condition in the body based on the identification of both the first and second analytes. In one embodiment, the first target condition is pregnancy, the first analyte is human chorionic gonadotropin (hCG) and the second analyte is luteinizing hormone (LH).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.